Will You Get Your Share Of GlaxoSmithKline plc’s £4bn Special Dividend?

Income favourite GlaxoSmithKline (LSE: GSK) has finalised its impressively ambitious three-part deal with Swiss giant Novatis, and thus its shareholders can now look forward to a £4 billion cash return. 

To find out the strategies to adopt if you want to become one of the growing number of surprise UK millionaires, read this FREE Motley Fool report: '7 Simple Steps For Seeking Serious Wealth' while it remains available!

Owain Bennallack owns shares in GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.